Spatial navigation deficits in early Alzheimer’s disease: the role of biomarkers and APOE genotype
Authors:
Open Access
- 2 June 2025
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (6) , 1-24
Abstract
Background: Spatial navigation deficits are early symptoms of Alzheimer’s disease (AD). The apolipoprotein E (APOE) ε4 allele is the most important genetic risk factor for AD. This study investigated effects of APOE genotype on spatial navigation in biomarker-defined individuals with amnestic mild cognitive impairment (aMCI) and associations of AD biomarkers and atrophy of AD-related brain regions with spatial navigation. Methods: 107 participants, cognitively normal older adults (CN, n = 48) and aMCI individuals stratified into AD aMCI (n = 28) and non-AD aMCI (n = 31) groups, underwent cognitive assessment, brain MRI, and spatial navigation assessment using the Virtual Supermarket Test with egocentric and allocentric tasks and a self-report questionnaire. Cerebrospinal fluid (CSF) biomarkers (amyloid-β1–42, phosphorylated tau181 and total tau) and amyloid PET imaging were assessed in aMCI participants. Results: AD aMCI participants had the highest prevalence of APOE ε4 carriers and worst allocentric navigation. CSF levels of AD biomarkers and atrophy in AD-related brain regions were associated with worse allocentric navigation. Between-group differences in spatial navigation and associations with AD biomarkers and regional brain atrophy were not influenced by APOE genotype. Self-reported navigation ability was similar across groups and unrelated to spatial navigation performance. Conclusions: These findings suggest that allocentric navigation deficits in aMCI individuals are predominantly driven by AD pathology, independent of APOE genotype. This highlights the role of AD pathology as measured by biomarkers, rather than genetic status, as a major factor in navigational impairment in aMCI, and emphasizes the assessment of spatial navigation as a valuable tool for early detection of AD.Keywords
This publication has 98 references indexed in Scilit:
- Clinical criteria for limbic‐predominant age‐related TDP‐43 encephalopathyAlzheimer's & Dementia, 2025
- Donanemab in Early Symptomatic Alzheimer DiseaseJAMA, 2023
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- The human posterior cingulate, retrosplenial, and medial parietal cortex effective connectome, and implications for memory and navigationHuman Brain Mapping, 2022
- Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-βJAMA Neurology, 2020
- From details to large scale: The representation of environmental positions follows a granularity gradient along the human hippocampal and entorhinal anterior–posterior axisHippocampus, 2014
- Hippocampal size predicts rapid learning of a cognitive map in humansHippocampus, 2013
- Longitudinal Patterns of β-Amyloid Deposition in Nondemented Older AdultsArchives of Neurology, 2011
- Cholinergic system regulation of spatial representation by the hippocampusHippocampus, 2002
- Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkeyJournal of Comparative Neurology, 1983